Results 11 to 20 of about 3,132,176 (310)

Soft Tissue Sarcomas

open access: yesCa-A Cancer Journal for Clinicians, 2004
Sarcomas are a heterogeneous group of rare tumors that arise predominantly from the embryonic mesoderm. They present most commonly as an asymptomatic mass originating in an extremity but can occur anywhere in the body, particularly the trunk, retroperitoneum, or the head and neck.
Raphael E Pollock, Janice N Cormier
exaly   +3 more sources

Immunotherapy in Soft-Tissue Sarcoma [PDF]

open access: yesCurrent Oncology, 2020
Soft-tissue sarcoma (sts) is a rare mesenchymal malignancy that accounts for less than 1% of all adult tumours. Despite the successful advancement of localized therapies such as surgery and radiotherapy, these tumours can, for many, recur—often with metastatic disease.
O, Ayodele, A R Abdul, Razak
openaire   +3 more sources

Sarcomas of the Soft Tissues [PDF]

open access: yesCa-A Cancer Journal for Clinicians, 1961
Arthur Purdy Stout
exaly   +3 more sources

Sarcoma of Soft Tissue [PDF]

open access: yesCa-A Cancer Journal for Clinicians, 1978
Herman D Suit
exaly   +3 more sources

Soft Tissue Sarcoma [PDF]

open access: yesJournal of the National Comprehensive Cancer Network, 2010
The soft-tissue sarcomas (STS) of childhood are a relatively rare and heterogeneous group of tumors that may occur anywhere in the body and respond quite differently to therapy. STSs account for 7.4% of all cancers in children younger than 20 years [1].
George D, Demetri   +23 more
openaire   +2 more sources

Avelumab use in Merkel cell carcinoma treatment

open access: yesNowotwory, 2022
Avelumab is a programmed death-ligand 1 (PD-L1) blocking human IgG1 lambda monoclonal antibody. It was the first immunotherapy to be approved for the treatment of MCC.
Monika Dudzisz-Śledź   +4 more
doaj   +1 more source

Definitive Radiotherapy in the Management of Non-Resectable or Residual Retroperitoneal Sarcomas: Institutional Cohort Analysis and Systematic Review

open access: yesCancer Control, 2021
Background: There is currently no consensus on optimal management of patients with primary or recurrent non-resectable/residual retroperitoneal sarcomas (RPS). The objective of this study was to document the outcomes of patients with primary or recurrent
Aleksandra Sobiborowicz   +3 more
doaj   +1 more source

Soft tissue sarcomas [PDF]

open access: yesCurrent Problems in Surgery, 1996
Soft tissue sarcomas are relatively rare tumors with an annual incidence of 5000 to 6000 in the United States. The primary therapy is surgical resection with an adequate margin of normal tissue. For patients at high risk local control is improved with postoperative adjuvant radiation. Local recurrence rates vary depending on the anatomic site.
J J, Lewis, M F, Brennan
openaire   +4 more sources

Late-onset meningeal metastases in liposarcoma: A case report and review of the literature [PDF]

open access: yes, 2006
Intracranial metastases from liposarcoma are rare and almost always preceded by the development of systemic tumour spread. We report here a case of liposarcoma with spread to the cranial nervous system 23 years after treatment of the primary tumour.
White, J.   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy